Lewicki John A.

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lewicki John A.'s trades of Mereo BioPharma Group PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-16 2024-09-13
S Sale
97,745 +11.5%
171.74
US$832,427 		97,745 +11.5% 171.74 US$832,427
2024-09-16 2024-09-12
S Sale
31,766 +36.6%
333.69
US$2,298,670 		31,766 +36.6% 333.69 US$2,298,670
2024-09-12 2024-09-12
PrS Proposed sale
64,649
308.60
US$797,151 		64,649 308.60 US$797,151
2024-06-27 2024-06-26
S Sale
16,808 -25.6%
3.39
US$57,033 		16,808 -25.6% 3.39 US$57,033
2024-06-27 2024-06-25
S Sale
7,416 -10.2%
3.69
US$27,394 		7,416 -10.2% 3.69 US$27,394
2024-06-24 2024-06-25
PrS Proposed sale
26,647
3.98
US$106,055 		26,647 3.98 US$106,055
2024-06-20 2024-06-21
PrS Proposed sale
26,647
3.98
US$106,055 		26,647 3.98 US$106,055